De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Lam Research Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Lam Research heeft een totaal eigen vermogen van $8.5B en een totale schuld van $5.0B, wat de schuld-eigenvermogensverhouding op 58.2% brengt. De totale activa en totale passiva bedragen respectievelijk $18.7B en $10.2B. De EBIT Lam Research is $4.3B waardoor de rentedekking -64.8 is. Het heeft contanten en kortetermijnbeleggingen van $5.8B.
Belangrijke informatie
58.2%
Verhouding schuld/eigen vermogen
US$4.97b
Schuld
Rente dekkingsratio | -64.8x |
Contant | US$5.85b |
Aandelen | US$8.54b |
Totaal verplichtingen | US$10.21b |
Totaal activa | US$18.74b |
Recente financiële gezondheidsupdates
Lam Research (NASDAQ:LRCX) Seems To Use Debt Quite Sensibly
Oct 12Here's Why Lam Research (NASDAQ:LRCX) Can Manage Its Debt Responsibly
Jun 06Lam Research (NASDAQ:LRCX) Has A Pretty Healthy Balance Sheet
Jan 28Is Lam Research (NASDAQ:LRCX) A Risky Investment?
Sep 27Is Lam Research (NASDAQ:LRCX) A Risky Investment?
Jun 29Is Lam Research (NASDAQ:LRCX) A Risky Investment?
Mar 20Recent updates
Lam Research (NASDAQ:LRCX) Seems To Use Debt Quite Sensibly
Oct 12Lam Research Following Micron's Footsteps In High Bandwidth Memory And Semiconductor Equipments Demand
Oct 11Lam Research: The Recent Pullback Is A Buying Opportunity
Sep 16Is Lam Research Corporation (NASDAQ:LRCX) Trading At A 36% Discount?
Sep 15Lam Research's (NASDAQ:LRCX) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 03Lam Research: Finding Opportunity Amidst Q4 FY 2024 Post Earnings Dip
Aug 16Lam Research: China Risk May Offset Memory Recovery And AI Boost
Aug 03The Lam Research Corporation (NASDAQ:LRCX) Full-Year Results Are Out And Analysts Have Published New Forecasts
Aug 02Investors Still Waiting For A Pull Back In Lam Research Corporation (NASDAQ:LRCX)
Jul 28Lam Research: It's Still All About Memory- Maintaining Buy
Jul 11Why Lam Research Corporation (NASDAQ:LRCX) Could Be Worth Watching
Jul 03Capitalizing On The Semiconductor Rebound: Lam Research Is A Compelling Buy
Jul 02Lam Research: Headwinds Coming From Chinese And Japanese Competitors
Jun 07Here's Why Lam Research (NASDAQ:LRCX) Can Manage Its Debt Responsibly
Jun 06Lam Research (NASDAQ:LRCX) Is Aiming To Keep Up Its Impressive Returns
May 23Lam Research: More Wafer Fab Equipment Spend For FY2025, Maintaining Buy
May 18Lam Research Corporation Just Beat EPS By 5.7%: Here's What Analysts Think Will Happen Next
Apr 26Lam Research: Benefiting From HBM-Driven DRAM; Initiate With 'Strong Buy'
Apr 18Lam Research: A Favorite In The Semis - Initiating With A Buy
Apr 09Why We're Not Concerned About Lam Research Corporation's (NASDAQ:LRCX) Share Price
Apr 04Lam Research: Stock Price Runup Justified But Upside Now Limited
Feb 24Here's What's Concerning About Lam Research's (NASDAQ:LRCX) Returns On Capital
Feb 22Investors Can Find Comfort In Lam Research's (NASDAQ:LRCX) Earnings Quality
Feb 09Lam Research Corporation (NASDAQ:LRCX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$872
Jan 31Lam Research (NASDAQ:LRCX) Has A Pretty Healthy Balance Sheet
Jan 28Lam Research: Lack Of Clarity On NAND A Significant Headwind In 2024
Jan 25Lam Research: Positioned Strongly (And Expensively) For AI Secular Trends
Jan 17Lam Research Corporation (NASDAQ:LRCX) Shares Could Be 25% Above Their Intrinsic Value Estimate
Jan 02Lam Research Corporation's (NASDAQ:LRCX) Price Is Out Of Tune With Earnings
Dec 21Why Lam Research Corporation (NASDAQ:LRCX) Could Be Worth Watching
Dec 09Lam Research (NASDAQ:LRCX) Might Become A Compounding Machine
Nov 15Is Lam Research (NASDAQ:LRCX) A Risky Investment?
Sep 27A Look At The Fair Value Of Lam Research Corporation (NASDAQ:LRCX)
Aug 30Why Lam Research Corporation (NASDAQ:LRCX) Could Be Worth Watching
Aug 17Lam Research (NASDAQ:LRCX) Could Become A Multi-Bagger
Jul 10Is Lam Research (NASDAQ:LRCX) A Risky Investment?
Jun 29If EPS Growth Is Important To You, Lam Research (NASDAQ:LRCX) Presents An Opportunity
Jun 07A Look At The Intrinsic Value Of Lam Research Corporation (NASDAQ:LRCX)
May 16Is It Too Late To Consider Buying Lam Research Corporation (NASDAQ:LRCX)?
May 05Why We Like The Returns At Lam Research (NASDAQ:LRCX)
Apr 01Is Lam Research (NASDAQ:LRCX) A Risky Investment?
Mar 20If EPS Growth Is Important To You, Lam Research (NASDAQ:LRCX) Presents An Opportunity
Mar 04Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( $12.9B ) LRCX } overtreffen de korte termijn passiva ( $4.3B ).
Langlopende schulden: De kortetermijnactiva LRCX ( $12.9B ) overtreffen de langetermijnschulden ( $5.9B ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: LRCX heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van LRCX is de afgelopen 5 jaar gedaald van 94.9% naar 58.2%.
Schuldendekking: De schuld van LRCX wordt goed gedekt door de operationele kasstroom ( 93.7% ).
Rentedekking: LRCX verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.